中药制剂联合化疗治疗老年晚期非小细胞肺癌疗效及成本效果分析.pdfVIP

山东医药2013 年第53 卷第26 期 中药制剂联合化疗治疗老年晚期非小细胞肺癌 疗效及成本效果分析 王燕莹，窦丽萍，钟慧 (上海中医药大学附属曙光医院，上海 201203 ) 摘要:目的探讨中药制剂联合化疗治疗老年晚期非小细胞肺癌的疗效及戚本效果。方法 选择全身化疗联 合中药静脉制剂治疗老年晚期非小细胞肺癌患者 120 例，随机分为康艾组、华蟠素组、艾迪组、参麦组(分别给予康 艾注射液、华嘴素注射液、艾迪注射液、参麦注射液) ，各 30 例。观察比较四组患者的临床疗效，并运用药物经济学 的方法对四种药物行戚本效果分析。结果 四种药物均能改善非小细胞肺癌的中医临床症状，其中艾迪组成本效 果比、增量成本一效果比分别为 148.57% 和 105.41% 。康艾组分别为 288.34% 、料。.44% ，参麦组分别为 157.13% 、23.ω% ，华糖素组成本效果比为 186.939岛，艾迪组成本效果比、增量成本一效果比最优。结论 化疗联 合艾迪注射液治疗老年晚期非小细胞性肺癌是较为合理、经济的治疗方案。 关键词:中药;非小细胞肺癌;药物治疗;药物成本;治疗效果 doi: 10. 3969/j. issn. 1∞12-266X. 2013. 26. ()(施 中固分类号:R734.2 文献标志码:A 文章编号:1∞2-266X(2013 )26，，(泊 18-04 Efficacy and cost-钳制iveness analysis of traditional Chinese medicine intravenous i 叫ections combined with chemotherapy in the elderly patients with advanced non-small-cell lung cancer 职4NG Yan-ying , DOU Li-ping , ZHONG Yi (Sh略uang Hospitαl 1\庐liated to Shanghai University 01 Traditional Chinese Medici肘， 8加ng加i 201203 , P. R. China) Abs缸act:Objective To investigate the curative effect and cost-effectiveness offo山kinds of 位aditional Chinese med- icine (TCM) injections combined with chemotherapy in the elderly patients wi由 advanced non-small-cell lung cancer. Metb俐Is A to凶。f 120 c喝ses of elderly patients with advanced non-small-cell lung cancer treated by traditional Chinese medicine intravenous injections combined wi也 chemotherapy were randomly divided into 4 groups , 30 in each group: 由e Kangai i时ection group , Cinobufotalin injection group , Aidi injection group and Shenmai injection 伊up. The clinical effi- cacy in fo山 groups was observed , and the cost-effectiveness analysis was conducted by pharmacoeconomics. Results All four injections could improve the clinical symptoms of TCM in the non-small